Although PTPN11 mutations have been documented in blastic phase CML, the p.G507V alteration is a novel variant in CML and has only been identified in other myeloid malignancies such as JMML, AML and MDS. This evidence concerns the gene PTPN11 and myelodysplastic syndrome.